During the epidemic period, 1.6 million boxes of drugs required for epidemic prevention in Xinjiang Victoria Pharmaceuticals

Pomegranate/Xinjiang Daily (Reporter Ma Bei reported) Urumqi City's temporary static management measures in key urban areas to ensure the needs of people in all ethnic groups. As a leading company in Xinjiang Pharmaceutical Industry, Xinjiang Uygur Pharmaceutical Co., Ltd. maintains normal production Operate. As of now, 1.6 million boxes of drugs have been produced, and more than 1.3 million boxes have been shipped to ensure the production and supply of drugs.

During the prevention and control of the epidemic, nearly 300 employees were stationed in various positions such as production, quality, research and development.

Employees of Xinjiang Uygur Pharmaceutical Co., Ltd. have stepped up medicines such as Zakuama particles and cold asthma Zopa particles. Photo by Long Simeng

The production workshop personnel actively produce the medicines required for epidemic prevention such as Zukama particles, cold asthma Zopa particles; quality management personnel strictly check the product quality inspection according to the production conditions, from the test of medicinal materials, intermediate products, finished products to the production process tracking supervision; logistics Managers conduct nucleic acid tests on the staff of the factory every day, disinfect key places, and guard the health and safety of employees in the factory.

During the epidemic, Xinjiang Uygur Pharmaceutical Co., Ltd. fully deployed the guarantee supply. Photo by Long Simeng

At the same time, as one of Urumqi City's key start -up project, Xinjiang Uygur Pharmaceuticals 100 million boxes of Uyghur Pharmaceutical Production Base Construction Projects -smart warehouses have reached the state of mid -checking at the end of July. It is expected to be completed by the end of November this year.

The project is located at No. 152 Central Asia Road North Road, Urumqi High -tech Industrial Development Zone (New City). The project construction time is from 2021 to 2026. The total investment is 295 million yuan, and the total construction area is 39,600 square meters.

The project construction content includes a new oral device workshop, purchased and installed with boiling granulator, particle packaging production lines, etc., produces Zukamu granules, compound Mikinizi granules, cold asthma Zopa granules, Yixin Badesran Giba granules Wait. Construction of intelligent warehouses in the new plant area, including the finished product library, cool library, etc., with a cargo position of 20,000. It adopts a full intelligent management system and can store more than 100 million boxes of Uyghur medicine products.

At present, Xinjiang Uygur Pharmaceuticals produces 14 million boxes of drugs including Zakimu particles, including 60 million boxes of drugs, which are 60 million boxes.

"After the project is completed, it can realize the capacity of 100 million boxes of Uyghur drugs an annual output of Uyghur medicine, and fundamentally solve the problem of warehousing." Said Dong Yuwei, assistant general manager of Xinjiang Uygur Pharmaceutical Co., Ltd.

- END -